Searched for
INDIA INJECTABLE GLP1 MARKET
Civil rights body asks National Human Rights Commission to step inA civil rights group has asked the NHRC to intervene in five maternal deaths. These deaths occurred in Kota, Rajasthan, after women receive...- Gush of Gulf sovereign wealth enters India in 2026Gulf sovereign funds invested $1.7 billion in India during the first half of 2026. This investment defied geopolitical tensions and fears o...
- Atharva Polyplast, Seemax Resources among 6 SME IPOs set to debut on bourses today. Check detailsSix SME IPOs are set to debut on the stock exchanges today, with Atharva Polyplast, Seemax Resources, Sampark India Logistics and Kratikal ...
- ‘Nobody should be left alone with a strong drug and a printout’: After Ketto, Kunal Kapoor’s next healthcare betAfter helping families finance critical treatments through Ketto, Kunal Kapoor is now focused on preventing those medical emergencies befor...
- Glenmark launches generic Olanzapine injection in USGlenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States, offering a treatment for schizophreni...
- Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareFive young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...
- Alibaba, Tencent back Kuaishou's Kling AI in $2.8 billion fundraiseChinese tech giant Kuaishou's AI video unit, Kling AI, has secured over 19 billion yuan ($2.80 billion) in funding from investors including...
- Japan-India Annual Summit: 150+ firms back $12.5 billion leap to fortify security tiesHe added a report by the Japanese newspaper The Yomiuri Shimbun, which noted that these initiatives, valued at approximately 2 trillion yen...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Adani, IHC plan to forge $11.5 billion aluminium unitAdani Group and Abu Dhabi's International Holding Company are set to invest a massive $11.5 billion in a new Odisha aluminium plant. This a...
- Nestle to cut artificial colourings from all products by end-2026Nestle is set to eliminate all artificial food colorings globally by the end of 2026, a significant move by the major food producer. This i...
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugsDespite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges wi...
- Global Market: PBOC keeps new overnight repo rate at 1.25%, pumps in 600 billion yuanChina's central bank significantly boosted liquidity, injecting 600 billion yuan via overnight reverse repos, doubling Monday's debut. This...
- Global Market: China's central bank expands liquidity toolkit with first-ever overnight reverse reposChina's central bank has introduced overnight reverse repo operations for the first time, injecting 300 billion yuan to manage liquidity. T...
- ITC's business with BAT grows 10% to Rs 1,587 crore in FY26, but dividend payout falls 9%ITC's business with major shareholder British American Tobacco (BAT) saw a 10% expansion in sales to Rs 1,587 crore in FY26, though dividen...
- Two British American Tobacco-linked entities receive Rs 3,896 crore ITC dividend in FY26British American Tobacco's Indian entities received ₹3,895.74 crore in dividends from ITC in FY26, a slight decrease from the previous year...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
Load More
